Fundraising Fox
/Companies
Sign in

Anumana

Cambridge, US · Founded 2020 · Delaware corporation · 3 known investors

Find your way into Anumana

Sign up to see every warm intro you have to Anumana

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Anumana team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making. Its portfolio includes FDA-cleared ECG-AI algorithms, generative imaging applications, and real-time procedural support tools for use across diagnostic and intraprocedural cardiac care.

AI & Machine LearningBiotechDigital HealthMedical Devices

Founders & leadership

Anumana was founded in 2020 by Murali Aravamudan.

MAMurali Aravamudan
Murali AravamudanExecutive Chairman of the Board; co-founder of nferenceCo-founder & CEO at Nference
MNMaulik Nanavaty
Maulik NanavatyChief Executive Officer
HF
Harris FishmanNamed on SEC filing
AC
Alan ColowickNamed on SEC filing
CR
Cheranjit RihalNamed on SEC filing
DG
David GoelNamed on SEC filingExecutive Officer at Matrix Capital Management
KB
Kyle BettigoleNamed on SEC filing

Investors · 3

MatrixreportedSan Francisco · $100K – $10M

How we know: funding news · press coverage · Not right? Tell us

Matrix Capital ManagementreportedPortsmouth

How we know: funding news · press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$32M disclosed across 1 round · 2022

▶$32MraisedNov 2022 · 72 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Murali AravamudanExecutive Officer, Director
  • Harris FishmanExecutive Officer
  • Alan ColowickDirector
  • Cheranjit RihalDirector
  • David GoelDirector
  • Kyle BettigoleExecutive Officer
Offering amount
$32M
Amount sold
$32M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
AktanaAktana provides a real-time orchestration platform for pharmaceutical marketing that coordinates digital and field engagement across channels to reach healthcare professionals at optimal times. The system delivers healthcare professional-level impact tracking and enables rapid campaign deployment for pharma companies and their marketing teams.
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.

Companies working in the same space as Anumana.

In the news

Anumana, Inc. announced that it has received funding from Boston Scientific Corporation, Matrix Capital Management, Mayo Clinic, Endowment Arm, Matrix Management Corporation, NTT Venture Capitalanumana.ai · Apr 2025

Frequently asked questions

What does Anumana do?
Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making. Its portfolio includes FDA-cleared ECG-AI algorithms, generative imaging applications, and real-time procedural support tools for use across diagnostic and intraprocedural cardiac care.
Who founded Anumana?
Anumana was founded by Murali Aravamudan in 2020.
Who are Anumana's investors?
Anumana's investors include NTT Venture Capital, Matrix, Matrix Capital Management.
How much funding has Anumana raised?
Anumana has disclosed $32M raised across 1 round.
Where is Anumana headquartered?
Anumana is headquartered in Cambridge, US.